In the News

Stay up to date with the latest news from Providence Cancer Institute Oregon. Sign up for our monthly research newsletter.

Follow us on social media:

Cancer survivorship: A guide to living with and beyond cancer
June is National Cancer Survivor Month, but we honor people with cancer, no matter where they are on their journey, every day of the year. Find out about the survivorship program at Providence Cancer
Attend free virtual event on MRI-guided radiation therapy for pancreatic cancer
Providence Cancer Institute presents a free virtual education event about MRI-guided radiation therapy and how it is used to treat pancreatic cancer.
Providence researchers contribute study findings at ASCO 2024 meeting, May 31- June 3
The annual meeting of cancer experts is a platform to collaborate and accelerate cancer research findings into clinical applications.
With the potential to transform cancer diagnostics, Providence contributes to innovative AI-powered digital pathology model
A joint study between Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model has been published in Nature.
2023 research report highlights breadth and impact of research at Providence
Providence researchers conducted over 2400 studies in 2023, according to the 2023 Providence Research Network Annual Report
Cancer studies seek to harness the power of the immune system
Explore three innovative studies targeting uveal melanoma, melanoma and head and neck squamous cell carcinoma. Learn why these studies offer hope for more effective cancer treatments.
Celebrating World Immunology Day
Providence Cancer Institute researcher shares her journey to immunology and the advice she has for those seeking a career in cancer research.
New vaccine being studied for HPV+ head and neck cancer
Researchers at Providence Cancer Institute are exploring a range of innovative approaches to targeting human papillomavirus-positive head and neck squamous cell cancer.
Looking ahead: Growth and advancements in surgical oncology at Providence Cancer Institute
Growing the surgical oncology programs at Providence Cancer Institute is a testament to our commitment to providing research-focused, comprehensive services and improving outcomes for patients.
Celebrating our oncology social workers
In recognition of National Social Work Month, Darlene Corral, LCSW, shares a little insight into the importance of oncology social workers.
Talking to an expert: The crucial role of nutrition in cancer care
In honor of National Nutrition Month® Alyssa George, MA, RDN, program manager at Oncology Nutrition, Providence Cancer Institute, talks about the important connection between cancer and nutrition.
How promoting apoptosis in new study may help people with cancer
In a new clinical trial open at Providence Cancer Institute, the therapy IGM-8444 aims to promote apoptosis, potentially slowing down the growth of DR5-positive tumor cells.
Dose-escalation studies aspire to fill gaps in cancer treatment options
Two early phase trials available at Providence Cancer Institute to evaluate escalating doses of different potential cancer treatments in patients with advanced solid tumors.
FDA approves cellular therapy, offering hope to more people with cancer
The Food and Drug Administration has approved an adoptive cell therapy for adult patients with melanoma that has spread to other parts of the body (metastatic).
Providence oncology nurse practitioner receives Values in Action Award
Jamie Zilverberg, MSN, FNP, AOCNP, receives the prestigious 2024 Values in Action Award, the highest honor given at Providence St. Joseph Health.
Celebrating Women in Science
In honor of International Day of Women and Girls in Science we highlight a researcher at Earle A. Chiles Research Institute, the research arm of Providence Cancer Institute.
Virtual education: Food and common cancer myths
Providence registered dietitian Christina Speaks, MS, RDN, LD, shares valuable information about food and common cancer myths.
Studies address need for more treatment options in endometrial cancer and AML
New study evaluates immunotherapy in combination with other medications in people with endometrial cancer, and a phase I trial for people with AML assesses a non-engineered natural killer cell therapy
Documentary film features Providence patients, researchers in pursuit of revolutionary cancer therapy
"Within Reach: The Fight to Finish Cancer" follows patient participants and teams of researchers and clinicians at Providence Cancer Institute working to create a living drug for incurable cancers.
Promising results of amivantamab studies appear in high-profile journals
New articles co-authored by Dr. Rachel Sanborn feature amivantamab studies for people with NSCLC.
A remarkable year of engagement and advancements at Providence Cancer Institute
Highlights from 2023 events, achievements and advancements at Providence Cancer Institute.
Meet Dr. Anderson: At home in Hood River, on a trail, beach or mountaintop
Providence hematology oncologist and outdoors enthusiast Eric C. Anderson, M.D., shares his love of the Pacific Northwest and his philosophy of care for patients.
Immunotherapies for GI and lung cancers evaluated in new studies
A study for people with GI cancers and two studies for people with advanced and early-stage lung cancer hope to develop better treatment options with the help of immunotherapy.
Genomic testing can improve outcomes for people with advanced cancer, study shows
Providence researchers say comprehensive genomic profiling can be pivotal in identifying gene mutations in a patient and tailoring personalized treatment strategies.
Providence researchers contribute to 21 studies at SITC2023
SITC 2023 provides a glimpse into scientific advances and breakthroughs in cancer immunotherapy by researchers from around the world.
Watch a free virtual talk on lung cancer prevention and treatment
Providence Cancer Institute lung cancer expert to present a virtual education talk on lung cancer screening, prevention and latest treatments.
New studies address unmet needs in treating triple-negative breast cancer
Two new studies available at Earle A. Chiles Research Institute, at division of Providence Cancer Institute of Oregon, to evaluate new treatments for triple-negative breast cancer.
Dr. Urba receives award for his contributions to science and community
Providence Cancer Institute of Oregon, and research director, Earle A. Chiles Research Institute, Walter J. Urba, M.D., Ph.D., receives award for his contributions to science and community.
Recognizing the important contributions of oncology APPs
Providence Cancer Institute celebrates Advanced Practice Providers Week from September 25 to 29 and recognizes their important contributions more than 25 clinics and programs.
New division director and deputy director of Hematology and Medical Oncology share a vision
Providence Cancer Institute of Oregon announces new division director and deputy director of Hematology and Medical Oncology.